EP Patent

EP2342198B1 — A diphosphate salt of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide

Assigned to Novartis AG · Expires 2013-04-03 · 13y expired

What this patent protects

Patent listed against sonidegib-phosphate.

Drugs covered by this patent

sonidegib-phosphate (SONIDEGIB PHOSPHATE)

Patent Metadata

Patent number: EP2342198B1
Jurisdiction: EP
Classification: —
Expires: 2013-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.